A Clinical study using healthy samples for the development of a clinical testing technology
Not Applicable
- Conditions
- healthy subject
- Registration Number
- JPRN-UMIN000046050
- Lead Sponsor
- Mibyou Life Science Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 216
Inclusion Criteria
Not provided
Exclusion Criteria
1)Those who are affected by any diseases 2)Those who always take medicines or get treatment regularly. 3)Those who have had a medical examination within a year and have a problem with their health 4)Those with severe allergic symptoms
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Small RNAs Leukocyte telomere length Protein markers
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are being explored for clinical testing technology in healthy subjects?
How does the intervention in JPRN-UMIN000046050 compare to standard-of-care for healthy subject studies?
What biomarkers are used for patient selection in Mibyou Life Science's clinical testing development?
What adverse events are associated with clinical testing technologies in healthy volunteers?
Are there related compounds or competitor drugs for clinical testing technology development in healthy populations?